New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 15, 2017 – Teva Pharmaceuticals launched an AB-rated generic version of Gilead’s Viread (tenofovir disoproxil fumarate) 300 mg tablets.
Download PDF
Return to publications